[1] The impact of active herpes simplex virus infection on human immunodeficiency virus load

[2] Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe

[3] Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression

[4] Selected P. falciparum specific immune responses are maintained in AIDS adults in Burkina Faso

[5] Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial

[6] Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults

[7] Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007

[8] Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study

[9] Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy

[10] CD4 and total lymphocyte counts as predictors of HIV disease progression

[11] National estimates of HIV-related symptom prevalence from the HIV Cost and Services Utilization Study

[12] Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group

[13] Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa

[14] Risk factors for helminth, malaria, and HIV infection in pregnancy in Entebbe, Uganda

[15] Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men

[16] Effect of combination antiretroviral therapy upon rectal mucosal HIV RNA burden and mononuclear cell apoptosis

[17] Use of corticosteroids in treating infectious diseases

[18] Clostridium difficile-associated diarrhea in HIV-infected patients: epidemiology and risk factors

[19] Evaluation of human immunodeficiency virus (HIV) type 1 RNA levels in cerebrospinal fluid and viral resistance to zidovudine in children with HIV encephalopathy

[20] Relation between stage of disease and neurobehavioral measures in children with symptomatic HIV disease

[21] Clonal dominance patterns of CD8 T cells in relation to disease progression in HIV-infected children

[22] Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy

[23] Induction of specific T-cell responses in HIV infection